ExploreInterventionChemotherapy
Intervention

Chemotherapy

Also known as: CHEMOTHER Chemotherapies Chemotherapy Chemotherapy-only treatment for childhood ALL (Total Therapy XV protocol) DRUG THER DT - Drug therapy Drug Therapies Drug Therapy Drug therapy Drug therapy (procedure) Drug therapy NOS Drug therapy NOS (procedure) +8 more
12 findings 2 papers 11 related entities View in graph →

Related entities

conditions
outcomes
populations
studys

Findings (50)

None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
decline

Leukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5

Size: RR=2.1 CI: 95% CI: 1.3, 3.5
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%
None
improvement

Long-term survivors of childhood ALL had significantly LOWER rates of Conduct Disorder (0.6% vs 10.9%) and Major Depressive Disorder (1.3% vs 15.4%) compared to the general population, suggesting prot

Effect: improvement; Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% expected; CI: 95% CI 0.0-3.5% (Conduct Disorder); 95% CI 0.2-4.6% (MDD)

Size: Conduct Disorder: 0.6% vs 10.9% expected; MDD: 1.3% vs 15.4% CI: 95% CI 0.0-3.5% (Conduct Disorder); 95%

Papers (2)